The new immunosuppressive agent FK778 attenuates neointima formation in an experimental venous bypass graft model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The new immunosuppressive agent FK778 attenuates neointima formation in an experimental venous bypass graft model

Published:2009-03 Issue:3-4 Volume:50 Page:83-88
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

de Graaf Rick,Kloppenburg Geoffrey,Tintu Andrei,Rouwet Ellen,Kitslaar Peter,van Hooff Johannes,Bruggeman Cathrien,Stassen Frank

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference29 articles.

1. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection;Bartlett;Agents Actions,1991

2. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators;Campeau;Circulation,1999

3. The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism;Cherwinski;J. Pharmacol. Exp. Ther.,1995

4. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency;Chesebro;N. Engl. J. Med.,1982

5. Genetic interventions for vein bypass graft disease: a review;Conte;J. Vasc. Surg.,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies to combat neointimal hyperplasia in vascular grafts;Expert Review of Cardiovascular Therapy;2012-05

2. “Venopathy” at work: recasting neointimal hyperplasia in a new light;Translational Research;2010-10

3. Mechanisms of Vein Graft Adaptation to the Arterial Circulation;Circulation Journal;2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3